Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Facebook
Site search
Search
Menu
Subscribe
Home
Contact Us
Terms of Use
Privacy Policy
Home Delivery
Subscribe
Submission Forms
Place an Ad
Weather
News
Sports
Entertainment
Calendar
Obituaries
Classifieds
Place an ad
e-Edition
Best of 2023
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Arcus Biosciences Inc
(NY:
RCUS
)
14.98
+0.28 (+1.90%)
Streaming Delayed Price
Updated: 10:43 AM EST, Nov 25, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Arcus Biosciences Inc
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
November 19, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
November 12, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Reports Third-Quarter 2024 Financial Results and Provides a Pipeline Update
November 06, 2024
From
Arcus Biosciences
Via
Business Wire
Expert Outlook: Arcus Biosciences Through The Eyes Of 8 Analysts
November 06, 2024
Via
Benzinga
Unveiling 5 Analyst Insights On Arcus Biosciences
October 21, 2024
Via
Benzinga
Where Arcus Biosciences Stands With Analysts
October 21, 2024
Via
Benzinga
Demystifying Arcus Biosciences: Insights From 4 Analyst Reviews
October 03, 2024
Via
Benzinga
Arcus Biosciences Announces that Domvanalimab Plus Zimberelimab Improved Overall Survival in ARC-10, a Randomized Study in Patients with PD-L1-High Non-Small Cell Lung Cancer
November 05, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Present New Data for Anti-TIGIT Domvanalimab Plus Zimberelimab at the Society for Immunotherapy of Cancer Annual Meeting
October 30, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
October 24, 2024
From
Arcus Biosciences
Via
Business Wire
Breaking Down Arcus Biosciences: 4 Analysts Share Their Views
August 09, 2024
Via
Benzinga
Cracking The Code: Understanding Analyst Reviews For Arcus Biosciences
July 08, 2024
Via
Benzinga
First Clinical Data for Arcus Biosciences’ HIF-2a Inhibitor, Casdatifan, Showed Promising Clinical Activity and Tumor Shrinkage in Patients with Metastatic Kidney Cancer
October 24, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Host Conference Call to Discuss Third-Quarter 2024 Financial Results and Pipeline Update
October 22, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
October 09, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Present First Clinical Data from ARC-20 Study at the 2024 EORTC-NCI-AACR Symposium
October 09, 2024
From
Arcus Biosciences
Via
Business Wire
This Abbott Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
October 08, 2024
Via
Benzinga
Arcus Biosciences Announces Clinical Trial Collaboration Agreement to Evaluate Casdatifan in Combination with Volrustomig in Renal Cell Carcinoma
October 02, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 24, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
September 10, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Secures Up to $250 Million Term Loan Facility from Hercules Capital
August 27, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
August 26, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences to Participate in Two Upcoming Investor Conferences
August 21, 2024
From
Arcus Biosciences
Via
Business Wire
RCUS Stock Earnings: Arcus Biosciences Beats EPS, Beats Revenue for Q2 2024
August 08, 2024
RCUS stock results show that Arcus Biosciences beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
Via
InvestorPlace
Arcus Biosciences Reports Second-Quarter 2024 Financial Results and Provides a Pipeline Update
August 08, 2024
From
Arcus Biosciences
Via
Business Wire
Sagimet Biosciences Announces Appointment of Anne Phillips and Jennifer Jarrett to its Board of Directors
August 01, 2024
From
Sagimet Biosciences Inc.
Via
GlobeNewswire
Arcus Biosciences to Host Conference Call to Discuss Second-Quarter 2024 Financial Results and Pipeline Update
July 25, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
July 09, 2024
From
Arcus Biosciences
Via
Business Wire
Taiho Pharmaceutical Exercises Option for an Exclusive License to Quemliclustat in Japan and Certain Territories in Asia
July 08, 2024
From
Arcus Biosciences
Via
Business Wire
Arcus Biosciences Announces New Employment Inducement Grants
June 25, 2024
From
Arcus Biosciences
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
10
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
